Beaverton OR Reliable and Affordable Web Design Services Released for Small Businesses - Press Release - Digital Journal

Beaverton OR Reliable and Affordable Web Design Services Released for Small Businesses - Press Release - Digital Journal

Beaverton OR Reliable and Affordable Web Design Services Released for Small Businesses - Press Release - Digital Journal

Posted: 11 Jan 2021 09:56 AM PST

Sharp Tack Media, a web design agency based in Portland, Oregon, announces the availability of its web design solutions for local businesses interested in maximizing their online visibility and attracting more potential customers in the Beaverton area. With a team of seasoned branding specialists, marketing strategists, graphic designers and web designers, the agency partners to provide outstanding personalized marketing strategies to every customer's needs.

This announcement is a reaction to the high demand for premium web design services in the current pandemic.

Sharp Tack Media Logo

Many Beaverton business establishments closed their doors when CoVID 19 hit the locality in March 2020, while some laid hundreds of employees, including the giant shoe manufacturer, Nike. The pattern seems to be shifting, however, with local companies reevaluating their strategies and making adjustments to the current situation.

One of the strategies implemented by many local businesses to stay afloat is to shift its efforts to online marketing and as such the Beaverton web design audience is hungry for new providers. As more goods and services are being migrated online, many consumers will continue to remotely for their necessities in offices and households.

Sharp Tack Media offers a wide range of services adapted to the needs of local businesses. It has developed industrialized web design strategies that are ideal for the increasing needs of the e-commerce industry.

The company also offers web design and creation, branding, marketing and graphic design services in a wide and complete range of solutions that make it efficient in handling diverse marketing needs.

The Oregon-based web design company uses realistic strategies to help small and medium businesses to increase their profits. The advantages and benefits of the tailored solutions and market insights offered by its highly qualified team of experts have been witnessed by current customers.

The agency's track record includes helping numerous clients see real results within less than 48 hours after the launch of their project. The high functionality of their websites , thoughtful branding techniques and quality content have provided important benefits in terms of managing clients' online reputation and authority.

The company also helps many businesses start-ups through its expert tips and advice. Local customers can opt for this consultation free of charge.

The firm has over 15 years of business experience partnering with hundreds of businesses across a variety of sectors, including HVAC companies, Home Services, Gyms and Fitness Practitioners, Medical Offices, Lawyers, Life Coaches, Ecommerce Shops, Supplement Companies, and many more.

Aside from its proven track record and efficient processes, the web design firm also emphasizes on its reasonable and affordable fees.

A company spokesperson says, "We pride ourselves on our strong small business web design experience, friendly customer service, straightforward process and great communication. We believe that this should not only reflect on how we manage our projects, but also on how we price them. We offer packages and services that are priced according to only what you need. We don't hide shady "fees'' that are phrased in such a way that you can't understand. Our clients can only expect that our breakdowns are fair and accurate and present all the information they need."

With this launch, Sharp Tack Media continues to advance online marketing strategies tailored to the needs of the current Beaverton local business community.

Interested parties can find more information on the agency's reliable and affordable online marketing services by visiting


For more information about Sharp Tack Media, contact the company here:

Sharp Tack Media
Deb Wise
(503) 782-8404
1500 Northwest Bethany Boulevard, Beaverton, OR, 97006

New Andress Artist & Entrepreneur Center opens soon - KTBS

Posted: 13 Jan 2021 06:50 PM PST

SHREVEPORT, La- The Andress Artist and Entrepreneur Center is opening in February in downtown Shreveport. The building was renovated after it was vacant for more than 30 years. On the first floor artists can rent booths as a work space. They are expected to move in around mid-February.

Andress Artist and Entrepreneur Center

Entrepreneurs can lease office space upstairs. As of Wednesday, every office had been leased before renovations were complete. They'll be able to move in, in early February. Jim Malsch, the managing member of the center spoke about the new development and the type of businesses found inside. 

"There'll be an attorney up here that focuses on small businesses, they'll also be a web design company, marketing people, video game development company," said Malsch. "Like I said, just kind of developing a culture if you would, have where people can work together and have the support that they needed to grow their business,"

Malsch plans to open a retail space on the first floor called the Downtown Art House.  The opening is pending thanks to COVID-19. To get more details and to inquire on renting space click here.

WordPress Launches New Website Building Solution -

Posted: 13 Jan 2021 10:26 AM PST

WordPress is great. Its open-source platform makes it the perfect choice for developers and website creators alike, with almost total freedom over their designs.

In fact, with more than 35% of the entire internet using WordPress (including, you'd think that the company would be reluctant to change. However, Built By WordPress is something different. Rather than getting access to a platform on which you can build your own site, with Built By WordPress, you pay upwards of $4,900 to have a site built for you.

But isn't that defeating the entire point of WordPress? Let's take a look into the new program to work out what's going on.

What is Built By WordPress?

Built By WordPress is, basically, WordPress' team of experts acting as a web design agency and creating a bespoke website for you. You'll pay a fee to WordPress and they'll build you a site in return.

This might seem strange given that WordPress is so closely associated with its open-source platform that allows anyone to build a site, as long as they have web hosting.

However, WordPress has been trying to muscle-in to the website builder game for a while now. While its open-source platform is known as, it has its own website building solution called With, you'll get access to the platform but have to out everything else., on the other hand,  hosting, designing, and some other features are baked into the software, and you pay a monthly fee.

Built By WordPress is the next logical step and gives WordPress a foot in every area of the website development game: DIY jobs, assisted and managed DIY sites, and agency-side bespoke websites for clients.

Is Built By WordPress Right for Me?

WordPress is saying that its new service is perfect for online stores, educational websites, and service businesses.

Digging into the application process, WordPress also asks prospective clients to confirm the budget they have for the new site as well as a deadline for launching it.

Finally, it's also asking users to "Describe, in as much detail as possible, what your dream site will include," and to "consider both design and functionality."

Of course, there's nothing new here — you can already build sites like these on both and sites. The difference, of course, is that WordPress will do all of the building and development for you, rather than you doing it yourself.

So, if you're struggling for time or lacking the expertise (and have the requisite funds), a Built by WordPress site might be a good fit for you and your business. However, the level of aftercare from Built By WordPress sites remains to be seen — if you want to make copy changes or add new features, for example, will these cost extra? Plus, is there a retainer fee for Built By WordPress sites? We still don't know any the answers to these questions.

But if you're a small business looking to start out, we'd still recommend using a website builder tool. They have significantly lower upfront costs and will likely give you more flexibility and control over your site.

If you want to create an online store, we'd recommend Shopify, for example. If you want to create a site for a small business, Wix or Squarespace would both be great choices.

0 out of 0
  • backward
  • forward
About our links is reader-supported. If you make a purchase through the links on our site, we may earn a commission from the retailers of the products we have reviewed. This helps to provide free advice and reviews for our readers. It has no additional cost to you, and never affects the editorial independence of our reviews. Click to return to top of page

Website design tech startup Webflow raises $140 million - Yahoo Finance

Posted: 13 Jan 2021 06:00 AM PST


These 2 Penny Stocks Could Surge Over 300%, Say Analysts

Risk and reward often travel hand-in-hand, making the stock market both lucrative and dangerous. Among the best exemplars of this axiom are the penny stocks, those equities priced at $5 or less. With that low price comes the potential for extreme gains, as even an incrementally small price increase will translate to a high percentage gain.JPMorgan's Head of Small and Midcap Equity Strategy, Eduardo Lecubarri, sees both the opportunities and dangers in the current market environment – and the great potential of small-cap stocks that have room to run."1Q may be rocky following the strong gains since Nov and the fact that valuations are sitting on all-time highs. However, the year long outlook is encouraging due to far more powerful fundamental tailwinds. Such a positive backdrop is likely to keep investors chasing those few stocks that still offer big recovery upside, as they seem to have started to do YTD. It is for this reason that we would encourage investors to build their portfolios now and see things through in the event of any consolidation phase that may come in Q1," Lecubarri wrote.Taking the risk into consideration, we used TipRanks' database to find compelling penny stocks with bargain price tags. The platform steered us towards two tickers sporting "Strong Buy" consensus ratings from the analyst community. Not to mention substantial upside potential is on the table. We are talking returns of at least 300% over the next 12 months, according to the analysts.AcelRx Pharmaceuticals (ACRX)Opioids have made headlines in recent years, and for all the wrong reasons. These potent pain relief drugs are also dangerously addictive – a factor that has led to the opioid epidemic in the US. AcelRx is a pharmaceutical company dedicated to the creation of safer treatments for acute pain, developing synthetic opioid drugs for sublingual (under the tongue) dosing.The company's main product, Sufentanil, was approved by the FDA under the name Dsuvia in 2018, and by the EU as Dzuveo that same year. A second sublingual Sufentanil system, under the name Zalviso, has also been approved for use by the EU, and is in Phase 3 trial in the US.In its most recent earning report, the company showed $1.4 million at the top line, driven by $1.3 million in product sales. The sales figure was up 433% sequentially, and the total revenue figure was up 133% year-over-year.Against this backdrop, several members of the Street believe ACRX's $1.40 share price looks like a steal.Cantor analyst Brandon Folkes is upbeat on Dsuvia's prospects as an alternative to current opioid treatments, and he believes that potential will boost the company's stock."With the launch of Dsuvia, we believe investor focus can now shift to launch metrics and peak sales potential for the product. As ACRX launches a true alternative to IV opioids, we expect investors to begin to appreciate the value of the product. We believe that Dsuvia offers an advancement in delivery of adequate pain treatment by eliminating the need for an invasive and time-consuming IV set-up in the emergency room, as well as an outpatient, or post-surgery, setting. Despite hospital launches taking time, we expect the uptake of Dsuvia to drive revenue upside beyond the Street's current estimates, which, in turn, could drive the stock higher from current levels," Follked opined.In line with his bullish stance, Folkes rates ACRX a Buy, and his $9 price target implies room for a stunning 552% upside potential in the next 12 months. (To watch Folkes' track record, click here)Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, ACRX has a Strong Buy consensus rating. Based on the $7 average price target, shares could soar 407% in the next year. (See ACRX stock analysis on TipRanks)NuCana (NCNA)NuCana is a biopharma company focused on new cancer treatments. The company's goal is to provide effective treatments for biliary, breast, colorectal, ovarian, and pancreatic cancers – while avoiding the complications and side effects of current chemotherapy treatments. NuCana uses a phosphoramidate chemistry technology called ProTide to create a class of drugs that will surmount the limitations of the existing nucleotide analogs behind many chemotherapy drugs. NuCana's ProTides have already been used in Gilead's antiviral drug Sovaldi.In May of last year, NuCana announced the restart of its Phase III trial on Acelarin, the drug candidate furthest along the company's pipeline, as a treatment for biliary tract cancers. The study encompasses over 800 patients in 6 countries and is currently ongoing. In November, the company published data described as 'encouraging' from the Phase Ib study of the same drug.While Acelarin is the flagship drug in the pipeline, NuCana has two other prospects under development. NUC-3373 is in Phase I trial as a treatment for solid tumors and colorectal cancers, and NUC-7738 is a second pathway under investigation for applications to advanced solid tumors. Of these three, the colorectal study is the farthest advanced.Writing from Truist, 5-star analyst Robyn Karnauskas sees the pipeline as key to NuCana's investor potential."We believe investors have overlooked the fact that NCNA is a platform Company that we believe is validated, as defined by the production of clinical products. We like that it has brought 3 products to the clinic, including one novel drug and two improved cornerstone chemos. The data suggest to us that the platform works and can produce better chemos […] While investors are mostly focused on Acelarin, we believe investors should also focus on NUC-3373, another core to our platform-based thesis that has data expected in 1H2021," Karnauskas noted.To this end, Karnauskas puts a $22 price target on NCNA, suggesting the stock has room for 384% growth ahead of it, along with a Buy rating. (To watch Karnauskas' track record, click here)Overall, NCNA's Strong Buy consensus rating is unanimous, and based on 4 recent reviews. Shares have an average price target of $17.33, suggesting a 270% one-year upside from the current trading price of $4.69. (See NCNA stock analysis on TipRanks)To find good ideas for penny stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a newly launched tool that unites all of TipRanks' equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.


Popular posts from this blog

10 Best New Age Business Ideas - CT Post

COVID-19: New business ideas emerge as people work from home - The Jakarta Post - Jakarta Post

Florida unemployment system set up to discourage benefit-seekers: governor - Business Insider - Business Insider